Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / swk holdings subsidiary enteris biopharma received 5

CARA - SWK Holdings' subsidiary Enteris BioPharma received $5M milestone payment from Cara Therapeutics

Cara Therapeutics Inc.
SWK Holdings (NASDAQ:SWKH) wholly-owned subsidiary, Enteris BioPharma received a $5M milestone payment from Cara Therapeutics (NASDAQ:CARA) related to the license agreement for Peptelligence oral formulation technology utilized in Oral KORSUVA. Enteris is entitled to retain $3M of this payment per the contractual splits agreed to in the Enteris acquisition agreement. Since license inception, Enteris has received $28M of payments from Cara; of the $20M of payments received subsequent to SWK's acquisition of Enteris in 2019, $9.9M was retained by Enteris. Cara expects to report top line data from an ongoing Phase 2 clinical trial evaluating Oral KORSUVA as a treatment for pruritis in patients with hepatic impairment due to primary biliary cholangitis.

For further details see:

SWK Holdings' subsidiary, Enteris BioPharma received $5M milestone payment from Cara Therapeutics
Stock Information
Company Name: Cara Therapeutics Inc.
Stock Symbol: CARA
Market: NASDAQ
Website: caratherapeutics.com
Menu
CARA CARA Quote CARA Short CARA News CARA Articles CARA Message Board
Get CARA Alerts

News, Short Squeeze, Breakout and More Instantly...